3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
7
Lymphoma, B-Cell
5
Lymphoma
5
Rhabdoid Tumor
3
Neoplasms
3
Medulloblastoma
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pinealoma
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms, Germ Cell and Embryonal
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Ganglioneuroblastoma
2
Ependymoma
2
Enteropathy-Associated T-Cell Lymphoma
2
Brain Neoplasms
2
Solid Tumor
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Recurrence
1
Pyloric Stenosis, Hypertrophic
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Interventions
fludarabine
7
Whole-Body Irradiation
6
Cyclophosphamide
6
venetoclax
5
fludarabine phosphate
5
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Busulfan
4
asciminib
3
gilteritinib
2
blinatumomab
2
aldesleukin
2
Patient Reported Outcome Measures
2
Mesna
2
Melphalan
2
Interleukin-2
2
Idarubicin
2
Cytarabine
2
Bone Marrow Transplantation
2
Azacitidine
2
ponatinib
1
nilotinib
1
nicotinamide-beta-riboside
1
methanesulfonic acid
1
enasidenib
1
Thiotepa
1
Stem Cell Transplantation
1
Social Determinants of Health
1
Sirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid
×
etoposide phosphate
×
1 year
×
Clear all
No trials found.